Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Jonathan Jay Mazelsky

At a glance: Jonathan Jay Mazelsky is Chair at Idexx Laboratories (IDXX). Their latest SEC Form 4, filed Nov 5, 2026, reported a sale of $1.4M. On file: 1 purchase line ($101K) and 26 sale lines ($33.0M).

Disclosed holdings: about $57.9M of IDXX stock: 83,803 shares reported on their latest Form 4 (filed Nov 5, 2026), valued at the Nov 19, 2026 close of $690.95. This counts only IDXX shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO, President at Idexx Laboratories Inc /De (IDXX); Chair at Idexx Laboratories Inc /De (IDXX); Director at DENTSPLY SIRONA Inc. (XRAY)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-1.8%
vs. S&P 500-2.8%
Beat the market0%
Paper profit on buys−$18K
Total bought / sold$101K / $33.0M

Jonathan Jay Mazelsky's InsiderPrint

27 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.

InsiderPrint of Jonathan Jay Mazelsky: 27 trades, 2026 to 20262026: 1 buy, 26 sales

Reading this print: Almost only sells, trading about 27 times a year, typically $976K a trade.

  • Bump outward: a purchase (1)
  • Dent inward: a sale (26)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Strauss ZelnickDirector · STWD · 99% match
  2. Jeffrey FlugDirector · PNNT · 94% match
  3. Jamere JacksonCFO · AZO · 94% match
  4. Satish DhanasekaranCEO, President · KEYS · 94% match
  5. Jason AryehDirector · LGND · 94% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 1,945106,998 held (−2%) $698.26 $1.4M -1.0%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 4,075102,923 held (−4%) $699.33 $2.8M -1.2%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 1,667101,256 held (−2%) $700.33 $1.2M -1.3%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 4,54096,716 held (−4%) $701.36 $3.2M -1.5%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 2,13694,580 held (−2%) $702.21 $1.5M -1.6%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 3,95090,630 held (−4%) $703.45 $2.8M -1.8%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 24090,390 held (−0%) $705.59 $169K -2.1%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 84089,550 held (−1%) $707.00 $594K -2.3%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 1,84087,710 held (−2%) $707.84 $1.3M -2.4%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 1,30086,410 held (−1%) $709.00 $922K -2.5%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 1,50184,909 held (−2%) $710.12 $1.1M -2.7%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 77584,134 held (−1%) $711.31 $551K -2.9%
Nov 5SEC IDXXIdexx Laboratories Inc /De Sell 33183,803 held (−0%) $711.95 $236K -2.9%
Jun 18SEC XRAYDENTSPLY SIRONA Inc.First buy Buy 10,00061,669 held (+19%) $10.14 $101K -17.5%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,281105,651 held (−1%) $650.67 $834K +6.2%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,095104,556 held (−1%) $651.49 $713K +6.1%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,669102,887 held (−2%) $652.49 $1.1M +5.9%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,171101,716 held (−1%) $653.68 $765K +5.7%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,111100,605 held (−1%) $654.63 $727K +5.5%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,48899,117 held (−1%) $655.85 $976K +5.4%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,34397,774 held (−1%) $656.85 $882K +5.2%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 2,86094,914 held (−3%) $657.84 $1.9M +5.0%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 3,66091,254 held (−4%) $658.92 $2.4M +4.9%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 2,85988,395 held (−3%) $659.75 $1.9M +4.7%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,20087,195 held (−1%) $661.10 $793K +4.5%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 1,00086,195 held (−1%) $662.16 $662K +4.3%
Mar 2SEC IDXXIdexx Laboratories Inc /De Sell 2,58983,606 held (−3%) $663.04 $1.7M +4.2%
  • Buy

    Director Jonathan Jay Mazelsky bought $101K of XRAY at $10.14 — first open-market purchase in our records.

Follow Jonathan Jay Mazelsky

Get one email when Jonathan Jay Mazelsky files a new purchase or sale. Free.

At most one email a day about Jonathan Jay Mazelsky, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.